Transforming the treatment of
fibro-inflammatory diseases
Developer of first-in-class therapeutics targeting the IL-11 pathway
Our Focus
IL-11 signalling is a fundamentally important driver of fibrogenesis, organ dysfunction and inflammation across human fibrotic diseases.
![](https://www.enleofen.com/wp-content/uploads/2019/01/enloefen-new-img-1.png)